68136067MU028L0medical innovation,health technology assessment,health economic evaluation,target product profiles,research and development

68305067HI027L0Research capacity building,health technology assessment,policy decision making,multidisciplinary research network,international collaboration

68137067RU024L0health economic evaluation,health technology assessment

In the Prince Mahidol Award Conference 2026 (PMAC 2026), held from January 26–31, 2026, at the Centara Grand & Bangkok Convention Centre at CentralWorld, the Health Intervention and Technology Assessment Program Foundation (HITAP) participated in supporting and driving the international exchange

Achieving universal health coverage (UHC) requires policy initiatives supported by long-term system reform and an accountable governance structure that can sustainably deliver all three dimensions of UHC, population coverage, breadth of benefits package, and degree of financial coverag

– NUHS telemedicine service was developed to improve patients’ and caregivers’ convenience in accessing patient care and to prepare for future crises that hinder in-person clinical consultation  – The key enablers of the telemedicine service were mainly due to strong cross-collaboration between t

In 2015, a HITAP International Unit (HIU) survey identified the major challenges (both contextual and technical) to the conduct of rigorous economic evaluations for policymakers’ use in healthcare decision making. • From this study, HITAP created an online platform called the Guide to health Econ

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo

Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage. Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca